Focus Partners Wealth’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-37,116
Closed -$3.54M 2713
2025
Q4
$3.54M Buy
37,116
+16,021
+76% +$1.29M ﹤0.01% 1091
2025
Q3
$1.22M Sell
21,095
-3,782
-15% -$189K ﹤0.01% 1207
2025
Q2
$1.32M Buy
24,877
+3,329
+15% +$169K ﹤0.01% 1032
2025
Q1
$933K Buy
21,548
+2,238
+12% +$113K ﹤0.01% 1091
2024
Q4
$1.09M Buy
19,310
+3,376
+21% +$210K ﹤0.01% 1027
2024
Q3
$1.09M Buy
+15,934
New +$899K ﹤0.01% 924

Other funds holding EXAS

Focus Partners Wealth's EXAS Position: Q1 2026 in Review

Focus Partners Wealth sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 37,116 shares — an estimated $3.54M sold.

Focus Partners Wealth first reported a position in EXAS in Q3 2024 and held it in 6 quarters. The position peaked at $3.54M in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Focus Partners Wealth reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Focus Partners Wealth sold 37,116 Exact Sciences shares in Q1 2026, an estimated $3.54M.
  • Focus Partners Wealth first reported a position in Exact Sciences in Q3 2024 and held it in 6 quarters.
  • Focus Partners Wealth's Exact Sciences position peaked at $3.54M in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.